MedTrace Logo

INtravesical Antimicrobial Agents v STANDard Oral Antibiotics for the Treatment of Acute UTI in Women With rUTI

NCT03299387 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2019-06-06

No results posted yet for this study

Summary

Women have problems with oral antibiotics, including vagina and bowel infections. Also, bacteria causing urinary infections are becoming more resistant to oral antibiotis. Placement of antibiotic directly into the bladder does not cause these problems and are at doses that are may be able to stop bacteria from being resistant to antibiotics.

Conditions

Interventions

DRUG

Nitrofurantoin

Participants will receive oral Nitrofurantoin 100 mg twice daily for 7 days

DRUG

Gentamicin

Participants will receive intravesical via catheter Gentamicin solution 25 mg in 50cc for 3 days

Sponsors & Collaborators

Principal Investigators

  • Deborah Lightner, MD · Mayo Clinic

  • Audrey N Schuetz, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-28
Primary Completion
2018-07-05
Completion
2018-07-05
FDA Drug
Yes

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03299387 on ClinicalTrials.gov